Abbott Laboratories ( ABT) - Stock Earnings

ABT Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
April 15, 2025 BeforeMarket - / - 10.0 billion - / 10.4 billion 10.7 billion

ABT Quarterly earnings

DateEarningsRevenue
2024Q3 1.6 billion USD 10.6 billion USD
2024Q2 1.3 billion USD 10.4 billion USD
2024Q1 1.2 billion USD 10.0 billion USD
2023Q4 1.6 billion USD 10.2 billion USD
2023Q3 1.4 billion USD 10.1 billion USD

ABT Yearly earnings

DateEarningsRevenue
2023 5.7 billion USD 40.1 billion USD
2022 6.9 billion USD 43.7 billion USD
2021 7.1 billion USD 43.1 billion USD
2020 4.5 billion USD 34.6 billion USD
2019 3.7 billion USD 31.9 billion USD

ABT

List: Contenders

Price: $131.79

52 week price:
99.71
132.26

5-year range yield:
1.39%
2.11%

Forward Dividend Yield: 1.79%

Payout Ratio: 69.40%

Payout Ratio Range:
-129.15%
247.91%

Dividend Per Share: 2.36 USD

Earnings Per Share: 7.68 USD

P/E Ratio: 16.81

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Volume: 5.1 million

Ebitda: 1.7 billion

Market Capitalization: 223.9 billion

Average Dividend Frequency: 4

Years Paying Dividends: 43

DGR3: 10.93%

DGR5: 12.50%

DGR10: 12.94%

DGR20: 19.33%

Links: